The Globe and Mail reports in its Wednesday, May 1, edition that RBC Dominion Securities analyst Drew McReynolds has reaffirmed his "sector perform" recommendation for Thomson Reuters. The Globe's David Leeder writes that Mr. McReynolds gave his share target a $3 boost to $153 (all figures U.S.). Analysts on average target the shares at $155.99. Mr. McReynolds says in a note: "At current valuation, we believe the bar to deliver consolidated organic revenue growth in excess of 6 per cent has risen with the organic revenue growth trajectory over the 2024-2026 period now taking centre stage. While we remain patient for more timely and/or attractive accumulation points following the run-up in the shares over the past year, we believe current valuation levels are fundamentally justified provided: (I) management meets or exceeds a 7- to 8-per-cent organic revenue growth trajectory by 2026 without meaningful changes to the company's current margin, capex and FCF conversion profile; (ii) solid execution on the GenAI playbook continues with little change to the current GenAI narrative including perceived opportunities and risks; and (iii) the valuation impact of interest rate expectations/bond yields at worst is neutral."